Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia
Authors
Keywords
-
Journal
Gastric Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-09
DOI
10.1007/s10120-021-01175-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Divergent mutational processes distinguish hypoxic and normoxic tumours
- (2020) Vinayak Bhandari et al. Nature Communications
- Association Between the Microsatellite Instability Status and the Efficacy of Postoperative Adjuvant Chemoradiotherapy in Patients With Gastric Cancer
- (2020) Dongfang Dai et al. Frontiers in Oncology
- Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer
- (2020) Lisheng Cai et al. Cancer Communications
- Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
- (2020) Qing Tao et al. Frontiers in Oncology
- ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines
- (2019) Norio Takei et al. BMC CANCER
- A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer
- (2019) Xiaohui Zhao et al. Gastric Cancer
- Tumor Mutation Burden and Prognosis in Colorectal Cancer Patients Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
- (2019) Dae-Won Lee et al. CLINICAL CANCER RESEARCH
- Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
- (2019) Filippo Pietrantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoantigen quality, not quantity
- (2019) Nicholas McGranahan et al. Science Translational Medicine
- Histone chaperone CHAF1A impacts the outcome of fluoropyrimidines-based adjuvant therapy in gastric cancer by regulating the expression of thymidylate synthetase
- (2019) Deqiang Wang et al. GENE
- Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer
- (2018) Yoon Young Choi et al. ANNALS OF SURGERY
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
- (2018) Hangcheng Fu et al. CLINICAL CANCER RESEARCH
- Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis
- (2018) Zhaolun Cai et al. Gastric Cancer
- Genetic and clonal dissection of osteosarcoma progression and lung metastasis
- (2018) Huaiyuan Xu et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
- (2018) Hira Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report
- (2018) Yuki Owada-Ozaki et al. Journal of Thoracic Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer
- (2018) Siddhartha Devarakonda et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of PD-L1 expression with tumor mutation burden and gene signatures for prognosis in early stage squamous cell lung carcinoma
- (2018) Hui Yu et al. Journal of Thoracic Oncology
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination
- (2018) Łukasz Kiraga et al. PLoS One
- PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer
- (2018) H. K. Angell et al. OncoImmunology
- CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
- (2017) Julia A. Wagner, Maximillian Rosario, Rizwan Romee, Melissa M. Berrien-Elliott, Stephanie E. Schneider, Jeffrey W. Leong, Ryan P. Sullivan, Brea A. Jewell, Michelle Becker-Hapak, Timothy Schappe, Sara Abdel-Latif, Aaron R. Ireland, Devika Jaishankar, Justin A. King, Ravi Vij, Dennis Clement, Jodie Goodridge, Karl-Johan Malmberg, Hing C. Wong, Todd A. Fehniger JOURNAL OF CLINICAL INVESTIGATION
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- The Warburg effect: 80 years on
- (2016) Michelle Potter et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
- (2016) Marte Jonsson et al. BRITISH JOURNAL OF CANCER
- Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer
- (2016) Elisabeth Brambilla et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
- (2014) H B Ragnum et al. BRITISH JOURNAL OF CANCER
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
- (2013) A. Eustace et al. CLINICAL CANCER RESEARCH
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search